Delivery Order SPE2DR25D2005-SPE2DR26FF0E8
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on January 7, 2026, for Lidocaine 5% Patch 30-count units with a firm fixed price ceiling value of $6,381.31 and an ultimate completion date of January 8, 2026. The contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Lidocaine patches are topical anesthetic products...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Lidocaine 5% Patch 30s with a ceiling value of $2,305.31. The contract was awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, and utilizes firm fixed price pricing. The award is unset-aside and competitively awarded, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 7, 2026, for Lidocaine 5% Patch 30s with a ceiling value of $5,336.70. This firm fixed-price delivery order is not set aside and is scheduled for ultimate completion by January 8, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,060.28 by the Defense Logistics Agency on January 7, 2026, for the supply of Lidocaine 5% Patch 30s. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location and an ultimate completion date of January 8, 2026. The delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively-awarded delivery order on October 21, 2025, by the Defense Logistics Agency to supply Lidocaine 5% Patch 30s with a ceiling value of $3,549.60. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 22, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $6,016.01. The contract is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and carries no set-aside designation. This award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lidocaine 5% patches (30-count units) with a ceiling value of $1,655.93. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its Pennsylvania location. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $10,311.22. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is set to be completed by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $7,490.10 delivery order by the Defense Logistics Agency on January 6, 2026, for the supply of Lidocaine 5% Patch 30s. The contract is non-competitive with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 7, 2026. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Lidocaine 5% Patch in a quantity of 30 units. This is a firm fixed price contract with a ceiling value of $5,710.63 and an ultimate completion date of July 22, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF0E8Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency (DLA) on January 7, 2026, for Lidocaine 5% patches (30-count units) with a ceiling value of $2,489.88. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 8, 2026. The award was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The DLA Troop Support Medical's Pharmaceutical Prime Vendor Global Program is planning to establish Generation V contracts with multiple regional awards, with Amerisourcebergen positioned to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/6/26 |